Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

Jacob M. Haus, Sangeeta R. Kashyap, Takhar Kasumov, Renliang Zhang, Karen R. Kelly, Ralph A Defronzo, John P. Kirwan

Research output: Contribution to journalArticle

295 Citations (Scopus)

Abstract

OBJECTIVE-To quantitate plasma ceramide subspecies concentrations in obese subjects with type 2 diabetes and relate these plasma levels to the severity of insulin resistance. Ceramides are a putative mediator of insulin resistance and lipotoxicity, and accumulation of ceramides within tissues in obese and diabetic subjects has been well described. RESEARCH DESIGN AND METHODS-We analyzed fasting plasma ceramide subspecies by quantitative tandem mass spectrometry in 13 obese type 2 diabetic patients and 14 lean healthy control subjects. Results were related to insulin sensitivity measured with the hyperinsulinemic- euglycemic clamp technique and with plasma tumor necrosis factor-α (TNF-α) levels, a marker of inflammation. Ceramide species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography. RESULTS-Insulin sensitivity (mg · kg -1 · min -1) was lower in type 2 diabetic patients (4.90 ± 0.3) versus control subjects (9.6 ± 0.4) (P < 0.0001). Type 2 diabetic subjects had higher (P < 0.05) concentrations of C18:0, C20:0, C24:1, and total ceramide. Insulin sensitivity was inversely correlated with C18:0, C20:0, C24:1, C24:0, and total ceramide (all P < 0.01). Plasma TNF-α concentration was increased (P < 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and C18:0 ceramide subspecies. CONCLUSIONS-Plasma ceramide levels are elevated in type 2 diabetic subjects and may contribute to insulin resistance through activation of inflammatory mediators, such as TNF-α.

Original languageEnglish (US)
Pages (from-to)337-343
Number of pages7
JournalDiabetes
Volume58
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Ceramides
Type 2 Diabetes Mellitus
Insulin Resistance
Tumor Necrosis Factor-alpha
Tandem Mass Spectrometry
Glucose Clamp Technique
Electrospray Ionization Mass Spectrometry
Fasting
Healthy Volunteers
Research Design
High Pressure Liquid Chromatography
Inflammation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. / Haus, Jacob M.; Kashyap, Sangeeta R.; Kasumov, Takhar; Zhang, Renliang; Kelly, Karen R.; Defronzo, Ralph A; Kirwan, John P.

In: Diabetes, Vol. 58, No. 2, 02.2009, p. 337-343.

Research output: Contribution to journalArticle

Haus, Jacob M. ; Kashyap, Sangeeta R. ; Kasumov, Takhar ; Zhang, Renliang ; Kelly, Karen R. ; Defronzo, Ralph A ; Kirwan, John P. / Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. In: Diabetes. 2009 ; Vol. 58, No. 2. pp. 337-343.
@article{cd2b74c5b0f940eea8c5acab6f2a1405,
title = "Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance",
abstract = "OBJECTIVE-To quantitate plasma ceramide subspecies concentrations in obese subjects with type 2 diabetes and relate these plasma levels to the severity of insulin resistance. Ceramides are a putative mediator of insulin resistance and lipotoxicity, and accumulation of ceramides within tissues in obese and diabetic subjects has been well described. RESEARCH DESIGN AND METHODS-We analyzed fasting plasma ceramide subspecies by quantitative tandem mass spectrometry in 13 obese type 2 diabetic patients and 14 lean healthy control subjects. Results were related to insulin sensitivity measured with the hyperinsulinemic- euglycemic clamp technique and with plasma tumor necrosis factor-α (TNF-α) levels, a marker of inflammation. Ceramide species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography. RESULTS-Insulin sensitivity (mg · kg -1 · min -1) was lower in type 2 diabetic patients (4.90 ± 0.3) versus control subjects (9.6 ± 0.4) (P < 0.0001). Type 2 diabetic subjects had higher (P < 0.05) concentrations of C18:0, C20:0, C24:1, and total ceramide. Insulin sensitivity was inversely correlated with C18:0, C20:0, C24:1, C24:0, and total ceramide (all P < 0.01). Plasma TNF-α concentration was increased (P < 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and C18:0 ceramide subspecies. CONCLUSIONS-Plasma ceramide levels are elevated in type 2 diabetic subjects and may contribute to insulin resistance through activation of inflammatory mediators, such as TNF-α.",
author = "Haus, {Jacob M.} and Kashyap, {Sangeeta R.} and Takhar Kasumov and Renliang Zhang and Kelly, {Karen R.} and Defronzo, {Ralph A} and Kirwan, {John P.}",
year = "2009",
month = "2",
doi = "10.2337/db08-1228",
language = "English (US)",
volume = "58",
pages = "337--343",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

AU - Haus, Jacob M.

AU - Kashyap, Sangeeta R.

AU - Kasumov, Takhar

AU - Zhang, Renliang

AU - Kelly, Karen R.

AU - Defronzo, Ralph A

AU - Kirwan, John P.

PY - 2009/2

Y1 - 2009/2

N2 - OBJECTIVE-To quantitate plasma ceramide subspecies concentrations in obese subjects with type 2 diabetes and relate these plasma levels to the severity of insulin resistance. Ceramides are a putative mediator of insulin resistance and lipotoxicity, and accumulation of ceramides within tissues in obese and diabetic subjects has been well described. RESEARCH DESIGN AND METHODS-We analyzed fasting plasma ceramide subspecies by quantitative tandem mass spectrometry in 13 obese type 2 diabetic patients and 14 lean healthy control subjects. Results were related to insulin sensitivity measured with the hyperinsulinemic- euglycemic clamp technique and with plasma tumor necrosis factor-α (TNF-α) levels, a marker of inflammation. Ceramide species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography. RESULTS-Insulin sensitivity (mg · kg -1 · min -1) was lower in type 2 diabetic patients (4.90 ± 0.3) versus control subjects (9.6 ± 0.4) (P < 0.0001). Type 2 diabetic subjects had higher (P < 0.05) concentrations of C18:0, C20:0, C24:1, and total ceramide. Insulin sensitivity was inversely correlated with C18:0, C20:0, C24:1, C24:0, and total ceramide (all P < 0.01). Plasma TNF-α concentration was increased (P < 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and C18:0 ceramide subspecies. CONCLUSIONS-Plasma ceramide levels are elevated in type 2 diabetic subjects and may contribute to insulin resistance through activation of inflammatory mediators, such as TNF-α.

AB - OBJECTIVE-To quantitate plasma ceramide subspecies concentrations in obese subjects with type 2 diabetes and relate these plasma levels to the severity of insulin resistance. Ceramides are a putative mediator of insulin resistance and lipotoxicity, and accumulation of ceramides within tissues in obese and diabetic subjects has been well described. RESEARCH DESIGN AND METHODS-We analyzed fasting plasma ceramide subspecies by quantitative tandem mass spectrometry in 13 obese type 2 diabetic patients and 14 lean healthy control subjects. Results were related to insulin sensitivity measured with the hyperinsulinemic- euglycemic clamp technique and with plasma tumor necrosis factor-α (TNF-α) levels, a marker of inflammation. Ceramide species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography. RESULTS-Insulin sensitivity (mg · kg -1 · min -1) was lower in type 2 diabetic patients (4.90 ± 0.3) versus control subjects (9.6 ± 0.4) (P < 0.0001). Type 2 diabetic subjects had higher (P < 0.05) concentrations of C18:0, C20:0, C24:1, and total ceramide. Insulin sensitivity was inversely correlated with C18:0, C20:0, C24:1, C24:0, and total ceramide (all P < 0.01). Plasma TNF-α concentration was increased (P < 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and C18:0 ceramide subspecies. CONCLUSIONS-Plasma ceramide levels are elevated in type 2 diabetic subjects and may contribute to insulin resistance through activation of inflammatory mediators, such as TNF-α.

UR - http://www.scopus.com/inward/record.url?scp=63249117466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63249117466&partnerID=8YFLogxK

U2 - 10.2337/db08-1228

DO - 10.2337/db08-1228

M3 - Article

VL - 58

SP - 337

EP - 343

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -